TY - CHAP
T1 - Inflammation Detection Using Ensemble Endoscopic Multimodal Assessment in Inflammatory Bowel Disease
AU - Kolawole, Bisi Bode
AU - Chaudhari, Ujwala
AU - Santacroce, Giovanni
AU - Zammarchi, Irene
AU - Del Amor, Rocio
AU - Meseguer, Pablo
AU - Buda, Andrea
AU - Bisschops, Raf
AU - Naranjo, Valery
AU - Ghosh, Subrata
AU - Iacucci, Marietta
AU - Grisan, Enrico
AU - Bhandari, Pradeep
AU - De Hertogh, Gert
AU - Ferraz, Jose G.
AU - Goetz, Martin
AU - Gui, Xianyong
AU - Hayee, Bu'Hussain
AU - Kiesslich, Ralf
AU - Metelli, Chiara
AU - Lazarev, Mark
AU - Panaccione, Remo
AU - Parra-Blanco, Adolfo
AU - Pastorelli, Luca
AU - Rath, Timo
AU - Røyset, Elin Synnøve
AU - Vieth, Michael
AU - Villanacci, Vincenzo
AU - Zardo, Davide
N1 - Publisher Copyright:
© 2024 IEEE.
PY - 2024
Y1 - 2024
N2 - Inflammatory bowel diseases (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC), present chronic inflammatory gastrointestinal disorders with substantial implications for patients' quality of life. Traditional endoscopic evaluation remain pivotal for monitoring and managing IBD. Recent advancements in Virtual Chromoendoscopy (VCE) technologies, such as Flexible Spectral Imaging Color Enhancement (FICE) and iScan with digital enhancement, offer noninvasive alternatives for evaluating gastrointestinal diseases. While overcoming some limitations of White Light Endoscopy (WLE), these technologies introduce challenges related to scoring systems and deep learning algorithm training due to the qualitative nature of existing endoscopic scores. To address these challenges, we propose a combination of a generative (cycleGAN) and an ensemble model that integrates assessments from white light endoscopy (WLE), and generated Virtual Chromoendoscopy (VCE) to enhance inflammation detection and prediction. The ensemble model aims to combine the strengths of diverse modalities, providing a holistic understanding of a patient's inflammation status. Experiments demonstrated in this paper show that by integrating endoscopic findings with other modalities using an ensemble learning method can greatly improve the accuracy of prediction of IBD.
AB - Inflammatory bowel diseases (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC), present chronic inflammatory gastrointestinal disorders with substantial implications for patients' quality of life. Traditional endoscopic evaluation remain pivotal for monitoring and managing IBD. Recent advancements in Virtual Chromoendoscopy (VCE) technologies, such as Flexible Spectral Imaging Color Enhancement (FICE) and iScan with digital enhancement, offer noninvasive alternatives for evaluating gastrointestinal diseases. While overcoming some limitations of White Light Endoscopy (WLE), these technologies introduce challenges related to scoring systems and deep learning algorithm training due to the qualitative nature of existing endoscopic scores. To address these challenges, we propose a combination of a generative (cycleGAN) and an ensemble model that integrates assessments from white light endoscopy (WLE), and generated Virtual Chromoendoscopy (VCE) to enhance inflammation detection and prediction. The ensemble model aims to combine the strengths of diverse modalities, providing a holistic understanding of a patient's inflammation status. Experiments demonstrated in this paper show that by integrating endoscopic findings with other modalities using an ensemble learning method can greatly improve the accuracy of prediction of IBD.
KW - Endoscopy enhancement
KW - Esemble learning
KW - Multiple instance learning
KW - Virtual Chromoendoscopy (VCE)
KW - White Light Endoscopy (WLE)
UR - https://www.scopus.com/pages/publications/85203333292
U2 - 10.1109/ISBI56570.2024.10635162
DO - 10.1109/ISBI56570.2024.10635162
M3 - Chapter
AN - SCOPUS:85203333292
T3 - Proceedings - International Symposium on Biomedical Imaging
BT - IEEE International Symposium on Biomedical Imaging, ISBI 2024 - Conference Proceedings
PB - IEEE Computer Society
T2 - 21st IEEE International Symposium on Biomedical Imaging, ISBI 2024
Y2 - 27 May 2024 through 30 May 2024
ER -